Navigation Links
Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL
Date:9/12/2013

luding full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-09/MACK]

--

Sangamo BioSciences, Inc. Research Report

On August 26, 2013, Sangamo BioSciences, Inc. (Sangamo) announced that it has signed a definitive agreement to acquire Ceregene, Inc. (Ceregene), a privately held biotechnology company focused on developing adeno-associated virus (AAV) gene therapies.The Company informed that in accordance with the terms of the agreement, Sangamo will issue to the stockholders of Ceregene 100,000 shares of Sangamo's common stock, representing less than 0.2% of Sangamo's total shares outstanding. Further, the Company has agreed to make contingent earn-out payments to the stockholders of Ceregene based upon revenues generated from license or sales transaction of certain existing products of Ceregene. Sangamo expects the acquisition to close in September 2013, and does not expect it to have any impact on the Company's financial guidance for full-year 2013 operating expenses or year-end cash balance. The Full Research Report on Sangamo BioSciences, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-09/SGMO]

--

PDL BioPharma, Inc. Research Report

On September 9, 2013, PDL BioPharma, Inc. (PDL) announced revenue guidance for Q3 2013. The Company expects revenues of approximately $97 million, as compared with revenues of $85 million reported in Q3 2012, representing an increase of 14.1% YoY. The Company informed that its revenue guidance is driven by increased Q2 2013 sales for Avastin, Herceptin, Lucentis, Xolair, Kadcyla, Perjeta, and Actemra, for which PDL receives royalties in Q3 20
'/>"/>

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. Puma Biotechnology Announces Completion of Private Placement
3. Animal Biotechnology - Technologies, Markets and Companies
4. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
5. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
9. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
10. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
11. Selexis SA to Present at Biotech Showcase 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , November 21, 2014 , ... responsable comercial   Mariano Rodríguez es elegid ... KLOX está en marcha para comenzar de ... cura de heridas de reciente aprobación en Europa   , ... compañía") se complace al anunciar los siguientes nombramientos: ...
(Date:11/21/2014)... CA (PRWEB) November 20, 2014 Author ... Short Walk to the Other Side” published as ... “Award-Winning Finalist in the “Fiction: Short Story” category of ... Jeffrey Keen, President and CEO of USA Book News, ... mainstream and independent publishers, including Simon & Schuster, Penguin, ...
(Date:11/21/2014)... BlueInGreen, LLC ( BlueInGreen® ) and ... PCI, Inc., leading suppliers of ozone process technology ... to provide a new state-of-the-art ozone system for ... Wastewater Treatment. The new ozone disinfection system ... dissolution technology, Pinnacle Ozone’s industry leading Zenith™ ozone ...
(Date:11/21/2014)... , Nov. 20, 2014 Polaris Group ... dosed in its Phase 1 trial of ADI-PEG ... the treatment of malignant pleural mesothelioma (MPM) and ... conducting clinical trials on ADI-PEG 20, both as ... the treatment of several other indications, including breast ...
Breaking Biology Technology:KLOX Technologies anuncia sus nombramientos ejecutivos 2KLOX Technologies anuncia sus nombramientos ejecutivos 3KLOX Technologies anuncia sus nombramientos ejecutivos 4KLOX Technologies anuncia sus nombramientos ejecutivos 5Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 2Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 3Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 4City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
... AUSTIN, Texas, March 1, 2012 The nonprofit American ... Ph.D., of the University of Illinois – Chicago (UIC) ... Farnsworth Excellence in Botanical Research Award. (Logo: ... is ABC,s co-founding Board of Trustees member, the late ...
... Reportlinker.com announces that a new market research ... Global Biotechnology Industry ... series on Biotechnology provides a collection of ... of research findings. The report offers a ...
... AHRO), a biotech company focused on the research and ... that it has initiated the first shipment of AHRO-001 ... partner CardioNova, Ltd., a Russia based biotech company responsible ... AHRO-001. The clinical-grade material will be used to commence ...
Cached Biology Technology:Professor Doel Soejarto to Receive ABC's Farnsworth Excellence in Botanical Research Award 2Professor Doel Soejarto to Receive ABC's Farnsworth Excellence in Botanical Research Award 3Professor Doel Soejarto to Receive ABC's Farnsworth Excellence in Botanical Research Award 4Global Biotechnology Industry 2Global Biotechnology Industry 3Global Biotechnology Industry 4Global Biotechnology Industry 5Global Biotechnology Industry 6AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001 2AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001 3
(Date:11/6/2014)... when that predator runs so fast that it essentially blinds ... the fastest creature on Earth. Some of these half-inch-long beetles ... miles per hour). The fastest human can do about five ... beetle, a person would have to hit 480 miles per ... peak speeds, everything becomes a blur. They can,t gather enough ...
(Date:11/5/2014)... his career to understanding the Earth,s climate and ... As deputy director and regional climatologist for the ... Institute, Redmond has more than three decades of ... climate data to the general public. , At ... on December 15-19, 2014 the American Geophysical Union ...
(Date:11/4/2014)... the right time might actually help boost a species, ... in understanding animal populations, pest control and managing fish ... journal Trends in Ecology and Evolution , a ... kind of positive population effect an overall species experiences ... the size and developmental stage of the creatures that ...
Breaking Biology News(10 mins):The tiger beetle: Too fast to see 2Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2When less is more: Death in moderation boosts population density in nature 2
... all holders of a valid press card / formal ... press facilities, including a working room and an interview ... to assist you in organising interviews with relevant experts. ... online at: http://www.eular.org/congress_press_registration.cfm , Please direct any ...
... populations have traditionally been thought of as ... in single-cell observational techniques, like flow cytometry, ... for the observation of individual microbes within ... and Biological Synthesis (NIMBioS) is now accepting ...
... Louis scientists are imitating nature as they attempt to solve ... tendon to bone. Their goal is to improve the ... the group of four tendons and muscles that surround the ... detach from the bone. Commonly thought of as a ...
Cached Biology News:Ecology of microbes focus of workshop 2Biomimetic patch to be tested on tricky tendon-to-bone repairs 2Biomimetic patch to be tested on tricky tendon-to-bone repairs 3Biomimetic patch to be tested on tricky tendon-to-bone repairs 4
... than western blotting. Get results sooner and save ... gel detection. Eliminates the need for a membrane ... All reagents are ready-to-use. No reagents to prepare ... 2 reagents required. Guarantees a simple to perform, ...
... variable angle system, 220-240 V, is used to ... DNA fragments by pulsed field gel electrophoresis (PFGE). ... variable-speed pump, 14 x 13 cm casting stand ... mm thick comb, screened cap, disposable plug molds, ...
High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....
... The RC DC protein assay kit I ... protein concentration in the presence of reducing agents ... a colorimetric assay. The kit includes reagents and ... RC reagent I, 250 ml RC reagent II, ...
Biology Products: